124 related articles for article (PubMed ID: 35850775)
1. How education and GDP drive the COVID-19 vaccination campaign.
Ngo VM; Zimmermann KF; Nguyen PV; Huynh TLD; Nguyen HH
Arch Public Health; 2022 Jul; 80(1):171. PubMed ID: 35850775
[TBL] [Abstract][Full Text] [Related]
2. Pandemic preparedness and COVID-19: an exploratory analysis of infection and fatality rates, and contextual factors associated with preparedness in 177 countries, from Jan 1, 2020, to Sept 30, 2021.
COVID-19 National Preparedness Collaborators
Lancet; 2022 Apr; 399(10334):1489-1512. PubMed ID: 35120592
[TBL] [Abstract][Full Text] [Related]
3. A Global Study on the Correlates of Gross Domestic Product (GDP) and COVID-19 Vaccine Distribution.
Basak P; Abir T; Al Mamun A; Zainol NR; Khanam M; Haque MR; Milton AH; Agho KE
Vaccines (Basel); 2022 Feb; 10(2):. PubMed ID: 35214724
[TBL] [Abstract][Full Text] [Related]
4. Is COVID-19 vaccine inequality undermining the recovery from the COVID-19 pandemic?
Suárez-Álvarez A; López-Menéndez AJ
J Glob Health; 2022 May; 12():05020. PubMed ID: 35604879
[TBL] [Abstract][Full Text] [Related]
5. Community Health Resources, Globalization, Trust in Science, and Voting as Predictors of COVID-19 Vaccination Rates: A Global Study with Implications for Vaccine Adherence.
Omidvar Tehrani S; Perkins DD
Vaccines (Basel); 2022 Aug; 10(8):. PubMed ID: 36016231
[TBL] [Abstract][Full Text] [Related]
6. Global diversity of policy, coverage, and demand of COVID-19 vaccines: a descriptive study.
Chen Z; Zheng W; Wu Q; Chen X; Peng C; Tian Y; Sun R; Dong J; Wang M; Zhou X; Zhao Z; Zhong G; Yan X; Liu N; Hao F; Zhao S; Zhuang T; Yang J; Azman AS; Yu H
BMC Med; 2022 Apr; 20(1):130. PubMed ID: 35369871
[TBL] [Abstract][Full Text] [Related]
7. An analysis of the COVID-19 vaccination campaigns in France, Israel, Italy and Spain and their impact on health and economic outcomes.
Antonini M; Eid MA; Falkenbach M; Rosenbluth ST; Prieto PA; Brammli-Greenberg S; McMeekin P; Paolucci F
Health Policy Technol; 2022 Jun; 11(2):100594. PubMed ID: 34976711
[TBL] [Abstract][Full Text] [Related]
8. Association between COVID-19 morbidity, mortality, and gross domestic product, overweight/ obesity, non-communicable diseases, vaccination rate: A cross-sectional study.
Oshakbayev K; Zhankalova Z; Gazaliyeva M; Mustafin K; Bedelbayeva G; Dukenbayeva B; Otarbayev N; Tordai A
J Infect Public Health; 2022 Feb; 15(2):255-260. PubMed ID: 35065358
[TBL] [Abstract][Full Text] [Related]
9. The effects of COVID-19 on domestic and international security in democratic and authoritarian regimes.
Topping K; Hosny Y; Hunter LY; Yang Y
Politics Life Sci; 2024; 43(1):34-59. PubMed ID: 38567782
[TBL] [Abstract][Full Text] [Related]
10. Registry Systems for COVID-19 Vaccines and Rate of Acceptability for Vaccination Before and After Availability of Vaccines in 12 Countries: A Narrative Review.
Papagiannis D; Malli F; Gourgoulianis KI
Infect Dis Rep; 2022 Feb; 14(1):121-133. PubMed ID: 35200443
[TBL] [Abstract][Full Text] [Related]
11. Finding the way forward: COVID-19 vaccination progress in Germany, Austria and Switzerland.
Desson Z; Kauer L; Otten T; Peters JW; Paolucci F
Health Policy Technol; 2022 Jun; 11(2):100584. PubMed ID: 34868834
[TBL] [Abstract][Full Text] [Related]
12. Efficiency in COVID-19 Vaccination Campaigns-A Comparison across Germany's Federal States.
Götz G; Herold D; Klotz PA; Schäfer JT
Vaccines (Basel); 2021 Jul; 9(7):. PubMed ID: 34358204
[TBL] [Abstract][Full Text] [Related]
13. Impact of the SARS-CoV-2 pandemic on vaccine-preventable disease campaigns.
Ho LL; Gurung S; Mirza I; Nicolas HD; Steulet C; Burman AL; Danovaro-Holliday MC; Sodha SV; Kretsinger K
Int J Infect Dis; 2022 Jun; 119():201-209. PubMed ID: 35398300
[TBL] [Abstract][Full Text] [Related]
14. Comparative value-based pricing of an Ebola vaccine in resource-constrained countries based on cost-effectiveness analysis.
Obeng-Kusi M; Erstad B; Roe DJ; Abraham I
J Med Econ; 2022; 25(1):894-902. PubMed ID: 35748085
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 Vaccination Coverage and Key Public Health Indicators May Explain Disparities in COVID-19 Country-Specific Case Fatality Rate Within European Economic Area.
Papadopoulos VP; Emmanouilidou A; Yerou M; Panagaris S; Souleiman C; Varela D; Avramidou P; Melissopoulou E; Pappas C; Iliadou Z; Piperopoulos I; Somadis V; Partsalidis A; Metaxa E; Feresiadis I; Filippou D
Cureus; 2022 Mar; 14(3):e22989. PubMed ID: 35415037
[TBL] [Abstract][Full Text] [Related]
16. Assessing Inequities in COVID-19 Vaccine Roll-Out Strategy Programs: A Cross-Country Study Using a Machine Learning Approach.
Kazemi M; Bragazzi NL; Kong JD
Vaccines (Basel); 2022 Jan; 10(2):. PubMed ID: 35214653
[TBL] [Abstract][Full Text] [Related]
17. The impact of the COVID-19 pandemic on global GDP growth.
Gagnon JE; Kamin SB; Kearns J
J Jpn Int Econ; 2023 Jun; 68():101258. PubMed ID: 37012983
[TBL] [Abstract][Full Text] [Related]
18. Impact and Cost-Effectiveness of Human Papillomavirus Vaccination Campaigns.
Portnoy A; Campos NG; Sy S; Burger EA; Cohen J; Regan C; Kim JJ
Cancer Epidemiol Biomarkers Prev; 2020 Jan; 29(1):22-30. PubMed ID: 31666282
[TBL] [Abstract][Full Text] [Related]
19. COVID-19 response in Colombia: Hits and misses.
Prada SI; Garcia-Garcia MP; Guzman J
Health Policy Technol; 2022 Jun; 11(2):100621. PubMed ID: 35340774
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
